• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Family haploidentical donor-derived cytokine-induced killer cell biotherapy combined with bortezomib in two patients with relapsed multiple myeloma in a non-allogeneic transplant setting.

作者信息

Zhou Xin, Zhu Jianping, Sun Hongli, Shao Lizheng, Xu Ming, Guo Hongfeng

出版信息

Leuk Lymphoma. 2013 Jan;54(1):209-11. doi: 10.3109/10428194.2012.701741. Epub 2012 Aug 13.

DOI:10.3109/10428194.2012.701741
PMID:22734810
Abstract
摘要

相似文献

1
Family haploidentical donor-derived cytokine-induced killer cell biotherapy combined with bortezomib in two patients with relapsed multiple myeloma in a non-allogeneic transplant setting.在非异基因移植背景下，采用家庭单倍体相合供者来源的细胞因子诱导的杀伤细胞生物疗法联合硼替佐米治疗两名复发多发性骨髓瘤患者。
Leuk Lymphoma. 2013 Jan;54(1):209-11. doi: 10.3109/10428194.2012.701741. Epub 2012 Aug 13.
2
Bortezomib with or without dexamethasone in relapsed multiple myeloma following allogeneic hematopoietic cell transplantation.硼替佐米联合或不联合地塞米松用于异基因造血细胞移植后复发的多发性骨髓瘤治疗
Haematologica. 2006 Jun;91(6):837-9.
3
[Bortezomib in multiple myeloma patients after allogeneic stem cell transplantation].硼替佐米用于异基因干细胞移植后的多发性骨髓瘤患者
Klin Onkol. 2010;23(4):242-4.
4
Bortezomib treatment followed by a second non-myeloablative allogeneic stem cell transplant in two previously autografted patients with multiple myeloma relapse.硼替佐米治疗后，对两名先前接受自体移植且多发性骨髓瘤复发的患者进行第二次非清髓性异基因干细胞移植。
Haematologica. 2005 Jun;90(6):861-2.
5
Use of bortezomib in the management of chronic graft-versus-host disease among multiple myeloma patients relapsing after allogeneic transplantation.
Haematologica. 2007 Sep;92(9):1295-6. doi: 10.3324/haematol.10820.
6
[Bortezomib plus dexamethasone treatment followed by reduced-intensity allogeneic stem cell transplantation for multiple myeloma refractory to high-dose chemotherapy with autologous transplantation].硼替佐米联合地塞米松治疗后行减低剂量异基因干细胞移植治疗自体移植高剂量化疗难治性多发性骨髓瘤
Rinsho Ketsueki. 2011 Mar;52(3):136-41.
7
Efficacy of bortezomib therapy for extramedullary relapse of myeloma after autologous and non-myeloablative allogeneic transplantation.硼替佐米治疗自体及非清髓性异基因移植后骨髓瘤髓外复发的疗效
Haematologica. 2005 Feb;90(2):278-9.
8
Analysis of the efficacy and toxicity of bortezomib for treatment of relapsed or refractory multiple myeloma in community practice.硼替佐米用于社区医疗中治疗复发或难治性多发性骨髓瘤的疗效及毒性分析
Haematologica. 2005 Jul;90(7):996-7.
9
[Current therapy for multiple myeloma].[多发性骨髓瘤的当前治疗方法]
Pol Arch Med Wewn. 2005 Oct;114(4):1030-6.
10
Skin lesions induced by bortezomib.硼替佐米诱发的皮肤损伤。
Haematologica. 2005 Dec;90(12 Suppl):ECR44.

引用本文的文献

1
Innovative Clinical Perspectives for CIK Cells in Cancer Patients.癌症患者中 CIK 细胞的创新临床观点。
Int J Mol Sci. 2018 Jan 25;19(2):358. doi: 10.3390/ijms19020358.
2
Cytokine-induced killer cells: A novel immunotherapy strategy for leukemia.细胞因子诱导的杀伤细胞：一种针对白血病的新型免疫治疗策略。
Oncol Lett. 2015 Feb;9(2):535-541. doi: 10.3892/ol.2014.2780. Epub 2014 Dec 8.
3
Cytokine-induced killer (CIK) cells in cancer immunotherapy: report of the international registry on CIK cells (IRCC).癌症免疫治疗中的细胞因子诱导杀伤（CIK）细胞：细胞因子诱导杀伤细胞国际注册报告（IRCC）
J Cancer Res Clin Oncol. 2015 May;141(5):839-49. doi: 10.1007/s00432-014-1864-3. Epub 2014 Nov 8.
4
Cell-based strategies to manage leukemia relapse: efficacy and feasibility of immunotherapy approaches.基于细胞的策略来管理白血病复发：免疫治疗方法的疗效和可行性。
Leukemia. 2015 Jan;29(1):1-10. doi: 10.1038/leu.2014.189. Epub 2014 Jun 12.
5
Short-course bortezomib-based retreatment for patients with multiple myeloma who had received bortezomib-thalidomide-dexamethasone (VTD) as an initial therapy: A single-center case series.以硼替佐米为基础的短疗程再治疗用于初始治疗采用硼替佐米-沙利度胺-地塞米松（VTD）方案的多发性骨髓瘤患者：一项单中心病例系列研究。
Exp Ther Med. 2014 Apr;7(4):977-981. doi: 10.3892/etm.2014.1496. Epub 2014 Jan 23.